📰 Microdose Psychedelic News
Page 3 - Microdose Psychedelic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Microdose Psychedelic. Real-time updates on events, politics, business and more.
January 7, 2021
Thanks to biotech-focused drug development, the emerging psychedelic industry is stronger than ever before. However, there is a hidden hero in the details of the numerous press releases pertaining to psychedelic medicine progress – the investment banks allowing this space to grow. Indeed, the sheer scale of psychedelic medicine’s agenda requires a lot of funding, and much of this funding is thanks to investment banks who enter agreements with psychedelic medicine companies. Though ther...
December 31, 2020
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission. 2020 has indeed brought forth unforeseen challenges into the world due to the global coronavirus pandemic. However, this year has also seen monumental victories for psychedelic medicine–a radical new hope for a brighter future. The current state of mental healthcare, which has been starkly exposed due to the pandemic, is seriously insufficient.There is a significant need...
December 18, 2020
This article was originally published on Microdose Psychedelic Insights and appears here with permission. The mantra of the emerging psychedelic medicine industry ought to be collaboration over competition. It seems that almost every week, a new collaboration or partnership is announced. Today, Canadian biotechnology company Entheon Biomedical announced a DMT drug supply agreement with the Calgary-based psychedelic company Psygen Labs Inc. Psygen will supply Entheon with DMT for upcoming ...
December 14, 2020
Microdose Psychedelic Insights is pleased to present our first custom event series, leveraging the platform strengths of our Psychedelic Operating System. Mydecine Speakers Series: Psychedelic Innovations is a virtual event that will explore how current research is igniting mainstream medical interest to unlock the potential of psychedelic therapies. We invite you to join us as we explore the incredible findings around current psychedelic research and potential paths to mainstream acceptance...